Author Title [ Type(Asc)] Year
Filters: Author is Xu, Hui  [Clear All Filters]
Journal Article
Liu L-P, Li Y-M, Guo N-N, Li S, Ma X, Zhang Y-X, Gao Y, Huang J-L, Zheng D-X, Wang L-Y, et al. Therapeutic Potential of Patient iPSC-Derived iMelanocytes in Autologous Transplantation. Cell Rep. 2019;27(2):455-466.e5.
Zhang L, Li J, Xu H, Shao X, Fu L, Hou Y, Hao C, Li W, Joshi K, Wei W, et al. Myc-Miz-1 signaling promotes self-renewal of leukemia stem cells by repressing Cebpα and Cebpδ. Blood. 2020.
Li Y, Li Y, Yin J, Wang C, Yang M, Gu J, He M, Xu H, Fu W, Zhang W, et al. A mitophagy inhibitor targeting p62 attenuates the leukemia-initiation potential of acute myeloid leukemia cells. Cancer Lett. 2021.
Wang L-Q, Yu P, Li B, Guo Y-H, Liang Z-R, Zheng L-L, Yang J-H, Xu H, Liu S, Zheng L-S, et al. miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways. Mol Oncol. 2018.
Li J, Zhang L, Yin L, Ma N, Wang T, Wu Y, Wang M, Yang X, Xu H, Hao C, et al. In vitro Expansion of Hematopoietic Stem Cells by Inhibition of Both GSK3 and p38 Signaling. Stem Cells Dev. 2019.
Jiang N, Guo F, Sun B, Zhang X, Xu H. Different Effects of Fluoride Exposure on the Three Major Bone Cell Types. Biol Trace Elem Res. 2019.
Guo M, Luo B, Pan M, Li M, Xu H, Zhao F, Dou J. Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer. Int Immunopharmacol. 2020;88:106850.